Technology Forum Exhibit Industry Roundtable Soapbox Session Expo & Welcome Reception
Delivery Science Meets Business Opportunities
CRS Innovation Sunday is all about the business of delivery science, taking innovative ideas and technologies into the commercial sector. All of these sessions give you new, important information on companies and technologies as well as great opportunities for networking face-to-face. This is the start of the CRS Annual Meeting program – don’t miss it!
Hosted by individual companies, these forums focus on in-depth facets of products and services that support research and development in delivery science and technologies. Technology Forums are open to all registered attendees.
View the presentations and schedule of the participating companies
||OctoPlus NV and Purac Biomaterials|
Co-Sponsored by Catalent
What’s new in delivery science? Come to the program where presenters “get up on their soapbox” to give you a quick glimpse of some of the most innovative technologies and products in development today. Linger to network with the presenters as you enjoy refreshments, compliments of our sponsor.
See presenting companies
Industry Roundtable: Global Perspectives on Emerging and Established Delivery Markets
A global panel of business development and R&D executives from Asia, Europe, and North America will provide insight on the latest trends, challenges, and needs they see in delivery science. Audience participation is welcome during this global and energetic mix of perspectives from
- large and small companies
- entrepreneurs and big pharma
- venture capitalists and researchers
- pharmaceutical and food industries
- multiple nations, expecting Brazil, Japan, South Korea, People’s Republic of China, United Kingdom, and United States
Moderator: Arthur J. Tipton
Ph.D., President and CEO
Southern Research Institute, U.S.A.
Art Tipton’s experience spans 25 years in the pharmaceutical industry and participation in all growth aspects of three drug delivery start-ups. He holds 31 U.S. patents with numerous international equivalentsand has more than He most recently served as senior vice president and general manager of Evonik – Birmingham Laboratories in Birmingham, Alabama, and on July 8, 2013, became the President and CEO of Southwest Research Institute. Tipton oversees this not for profit scientific research organization for advanced engineering research in materials, systems development, environment and energy, and preclinical drug discovery and development. Dr. Tipton is also a strong supporting member of CRS, serving in multiple roles of treasurer, board member, CRS Foundation board member, and has recently been named CRS president-elect.
Industry Roundtable Participants
Seyoon Kim, Ph.D., Manager, R&D Planning Team, R&D Center, Samyang Biopharmaceuticals Corporation, South Korea
Dr. Kim joins the roundtable, representing an innovative specialty pharmaceutical company from South Korea. He will speak informally on his role within the organization and with drug delivery system technologies. He will be available for Q&A.
Martin Kussmann, Ph.D., Head of Molecular Biomarkers Core; Nestlé Institute of Health Sciences SA, Switzerland
Dr. Kussmann brings to the roundtable a focus on developments in food research relative to human health. He developed the institute’s core facility and program covering proteomics, lipidomics, metabonomics and micronutrient analysis plus their translation into molecular phenotyping and diagnostics in humans. Trained as an analytical biochemist, Kussmann’s experience spans pharmaceutical, biotech, and nutritional disciplines.
Ichiro Nakatomi, Ph.D., President & CEO; NanoCarrier Co., Ltd., Japan
Dr. Nakatomi’s experience bridges industry, academic, and government collaborations, with leadership in entrepreneurial companies, leading to his being honored with The Entrepreneur of the Year Japan in 2002. In addition to leading research, Dr. Nakatomi also leads organizations focusing on intellectual property, and is the President elect of the Licensing Executives Society Japan. The mission of his company, NanoCarrier, is to improve as many patients’ quality of life as possible, serving as an innovative pharmaceutical company in oncology, developing anti-cancer drugs.
Peter Timmins, Ph.D., Executive Director, Drug Product Science and Technology, Research and Development, Bristol-Myers Squibb, United Kingdom
Dr. Timmins oversees an 11.2 acre research facility where scientists investigate new medicinal compounds and how they can be manufactured efficiently on a commercial scale. He will informally share his insight on his work within big pharma across several geographic areas, as well as his interest in controlled release delivery. Dr. Timmins research will be presented in the scientific session, Oral CR – Pharmaceutical Formulations, Technologies, and Development Strategies, on Tuesday.
Hank Wuh, MD, MPH, Founder, Chief Executive Officer, SKAI Ventures, LLC, U.S.A. and Chairman, TruTag Technologies, Inc.
With a corporate motto of “ Invent. Disrupt. Inspire,” we are sure to hear a lively presentation from Dr. Wuh. An orthopedic surgeon, inventor, and entrepreneur, Dr. Wuh has led the development of over twenty healthcare products from concept to global commercialization. SKAI Ventures is a Venture Accelerator that transforms ingenious ideas from research labs into disruptive technologies and high growth companies with global impact. TruTag Technologies is the world’s most advanced “edible bar code” that is indestructible, inert, encodes millions of combinations of spectral data, for the on dose authentication of food and medicine to address the $80 billion annual market of counterfeit drugs. TruTags, interestingly, may be used for certain CRS applications.
Exposition Grand Opening and Welcome Reception
17:30-19:30 - Exhibit Hall III
Come to the Exposition Hall for discovery, solutions, opportunities, and refreshments! Kicking off with the Sunday evening Exposition Grand Opening and Welcome Reception, the Exposition Hall will also be open Monday and Tuesday as the central hub for poster viewing, program breaks, prize drawings, and refreshments.